Article: CELGENE Corp.(multiple myeloma treatment gets orphan drug status)(Brief Article)

Article: FDA Grants Orphan Drug Designation for Novel Akt ...
Business Wire;  February 4, 2008 ;     700+ words ... ... FDA) has granted orphan drug designation to ... the treatment of multiple myeloma. VQD-002 is ... proliferation in multiple myeloma and many other ... cancers including multiple myeloma. Orphan drug designation significantly ...

Article: Celgene Corporation Receives Orphan Drug ...
PR Newswire;  October 8, 2001 ;     700+ words ... ... Immunomodulatory Drug), has been granted orphan drug designation by the U.S ... Administration (FDA) for multiple myeloma. Orphan drug status entitles Celgene to ... years of market exclusivity in multiple myeloma for REVIMID following FDA approval ...

Article: Proteolix's Carfilzomib Receives Orphan Drug ...
PR Newswire;  April 2, 2008 ;     700+ words ... ... the treatment of multiple myeloma. The orphan drug designation encompasses all subsets of multiple myeloma and Waldenstrom ... S. prevalence of multiple myeloma was 53,712 patients. The Orphan Drug Act provides the ...

Article: Celgene Receives Orphan Drug Designation For ...
Immunotherapy Weekly;  November 7, 2001 ;     700+ words ... ... IMiD), has been granted orphan drug designation by the U.S ... Administration (FDA) for multiple myeloma. Orphan drug status entitles Celgene to ... years of market exclusivity in multiple myeloma for Revimid following FDA approval ...

Article: terna Zentaris Partner, Keryx Biopharmaceuticals, Receives ...
PR Newswire;  September 16, 2009 ;     700+ words ... ... received orphan-drug designation ... treatment of multiple myeloma. In August ... refractory multiple myeloma and that ... perifosine gaining Orphan Drug Designation ... trial in multiple myeloma by year-end." About Orphan-Drug Designation ...

Article: FDA Grants Aplidin(R) Orphan Drug Status for the ...
PR Newswire Europe;  October 6, 2004 ;     700+ words ... ... has been granted orphan drug status by the ... the treatment of Multiple Myeloma (MM). This is the second orphan drug designation granted ... currently exists for multiple myeloma patients that ... The FDA's orphan drug designation for ...

Article: EntreMed's Thalidomide Analog Receives FDA Orphan ...
PR Newswire;  November 7, 2002 ;     700+ words ... ... thalidomide, ENMD 0995, received Orphan Drug designation from the Food and Drug ... the treatment of patients with multiple myeloma. Multiple myeloma, the second ... 11,000 deaths annually. FDA Orphan Drug designation encourages the development ...